Evidence map›Paper›PMID 36855775›Full record

ArticleClinical and translational medicine2023

Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy.

Xia Mao, Kexin Wang, Yudong Liu, Xiaohui Su, Anguo Wu, Lin Chen, Jiangrui Wang, Beilei Cai, Yanqiong Zhang, Feng Huang and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xia MaoResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Kexin WangResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Yudong LiuResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Xiaohui SuResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Anguo WuSichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, China.
Lin ChenResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Jiangrui WangPharmceutical Factory of the Chongqing Academy of Medica, Chongqing, China.
Beilei CaiSinomune Pharmaceutical Co., Ltd, Wuxi, China.
Yanqiong ZhangResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0002-9358-111X
Feng HuangSchool of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
Na LinResearch Center of Traditional Chinese Medicine theory and literatures, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

Beijing Municipal Natural Science Foundation 7212186China Academy of Chinese Medical SciencesNational Natural Science Foundation of China 81974526National Natural Science Foundation of China 82274176Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences CI2021A03807Technology R&D Project of Institute of Chinese Materia Medica 20211024The Fundamental Research Funds for the Central Public Welfare Research Institutes ZXKT22042
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug RepositioningGlomerulonephritis, MembranousPlant PreparationsHumansPlant Preparations

Identifiers

PMID36855775
PMCPMC9975455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.